PARP抑制剂在个性化治疗耐受性前列腺癌中的应用：临床病例

{"title":"PARP抑制剂在个性化治疗耐受性前列腺癌中的应用：临床病例","authors":"A.A. Gritskevich Gritskevich, T.P. Byteman Byteman, D.M. Monakov Monakov, I.G. Rusakov Rusakov, S.V. Mishugin Mishugin","doi":"10.18565/pharmateca.2023.11.113-118","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20153,"journal":{"name":"Pharmateca","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case\",\"authors\":\"A.A. Gritskevich Gritskevich, T.P. Byteman Byteman, D.M. Monakov Monakov, I.G. Rusakov Rusakov, S.V. Mishugin Mishugin\",\"doi\":\"10.18565/pharmateca.2023.11.113-118\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20153,\"journal\":{\"name\":\"Pharmateca\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmateca\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18565/pharmateca.2023.11.113-118\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmateca","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18565/pharmateca.2023.11.113-118","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}